Filing Flows › Vericel (VCEL) › Recalls, complaints & regulation
Vericel (VCEL): clinical trials
Vericel (VCEL) beyond its filings: 2 active clinical trials.
Vericel's latest quarter
Vericel, Q3 2026: revenue $85.4M (+26% year over year), operating margin 14.3%, net earnings $14.2M, operating cash flow $17.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Vericel have?
2 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.